|
Q-739
|
Tuesday, December 9, 2025 |
With regard to supervised consumption sites approved by Health Canada, since 2015 and broken down by year and by site: (a) how many complaints about a supervised consumption site have been received from law enforcement, and, for each complaint, what (i) was the reason for the complaint, (ii) were the name and location of the site, (iii) was the name of the law enforcement individual or entity that submitted the complaint; (b) how many times has law enforcement requested that a supervised consumption site be (i) relocated, (ii) closed, and, for each request, what was the reason for the request; and (c) for each instance in (b), did the government (i) revoke or amend the exemption for the site to operate, (ii) request or require that the site be relocated, (iii) take no action? |
Awaiting response |
Monday, January 26, 2026 |
|
Q-731
|
Tuesday, December 9, 2025 |
With regard to protected persons in Canada who made a refugee claim, since 2015 and broken down by year: what is the total number of claimants that (i) underwent, (ii) did not undergo, an immigration medical examination at the time they made their refugee claim? |
Awaiting response |
Monday, January 26, 2026 |
|
Q-730
|
Tuesday, December 9, 2025 |
With regard to medical examinations for foreign nationals who applied for permanent residence, since 2015 and broken down by year: (a) what is the total number of applicants that (i) completed, (ii) did not complete, an immigration medical examination; (b) of the applicants in (a)(i), how many applicants (i) were found to pose a risk to public health or safety, (ii) have not complied with mandatory medical surveillance conditions, (iii) have left Canada since their initial immigration medical examination to spend six or more months in a tuberculosis-designated country or territory; (c) of the applicants in (a)(ii), how many were granted permanent residency despite not completing an immigration medical examination; and (d) for each case in (b), how many applicants were (i) deemed medically admissible, (ii) deemed medically inadmissible, (iii) required to undergo further medical assessment or surveillance? |
Awaiting response |
Monday, January 26, 2026 |
|
Q-709
|
Monday, December 8, 2025 |
With regard to the Interim Federal Health Program and its expenditures: (a) what were the total annual expenditures under the program, for each fiscal year from 2016 through 2025-26 to date, broken down by (i) basic health services, (ii) supplemental health services, (iii) prescription drugs, (iv) dental services; (b) how many individuals were enrolled in the program or received the program coverage, for each fiscal year from 2016 through 2025-26 to date, broken down by (i) basic health services, (ii) supplemental health services, (iii) prescription drugs, (iv) dental services; (c) what was the total number of individuals covered under the program, for each fiscal year from 2016 through 2025-26 to date, further broken down by (i) province or territory of residence, (ii) gender, (iii) age group (under 18, 18-64, and 65+), (iv) country of origin; (d) what were the total payments made to healthcare providers under the program, for each fiscal year from 2016 through 2025-26 to date, broken down by (i) physicians, (ii) hospitals, (iii) pharmacies, (iv) dental providers, (v) province or territory; (e) what were the total administrative costs of the program, for each fiscal year from 2016 through 2025-26 to date, broken down by (i) costs associated with claims processing, (ii) costs associated with oversight and program management, (iii) fees paid to members of the Canadian Association of Blue Cross Plans; and (f) what measures have been implemented since 2016 to ensure transparency and accountability in the allocation and expenditure of funds under the program, including any audits, reviews or evaluations conducted, and what were the findings of such audits or reviews? |
Awaiting response |
Monday, January 26, 2026 |
|
Q-406
|
Friday, October 3, 2025 |
With regard to the funding of substance use and harm reduction programs, since January 2022: (a) which contribution agreements have provided funding that was used by recipients for the purchase or distribution of pipes, including through (i) the Substance Use and Addictions Program, (ii) the Emergency Treatment Fund, (iii) the Harm Reduction Fund, (iv) any other program run by Health Canada or the Public Health Agency of Canada; and (b) what are the details of each funding agreement which allowed for the purchase or distribution of pipes, including, for each, the (i) date, (ii) recipient, (iii) value of the agreement, (iv) location, (v) approximate number of pipes purchased, (vi) approximate value of the pipes, (vii) number of pipes distributed, (viii) amount of the agreement funding that was used to purchase the pipes? |
Answered |
Wednesday, November 19, 2025 |
|
Q-405
|
Friday, October 3, 2025 |
With regard to the Emergency Treatment Fund, since 2018: (a) what are the names and locations of all funding recipients; and (b) of the recipients in (a), what are the details, including the (i) total amount of funding they received, (ii) date they received the funding, (iii) description of what the funds were intended for, (iv) individual expenses claimed under the funding, (v) assets purchased with the funding? |
Answered |
Wednesday, November 19, 2025 |
|
Q-404
|
Friday, October 3, 2025 |
With regard to the Substance Use and Addictions Program, since January 2017: (a) what are the names and locations of all funding recipients; (b) for each recipient in (a), how much of the funding was used specifically for the purchase of substances, including the (i) name and type of the substance, (ii) total quantity purchased, (iii) unit cost of each substance; and (c) what was the total amount of the program funds used to purchase substances, broken down by the (i) name and type of the substance, (ii) total quantity purchased, (iii) average unit cost of each substance, (iv) date of the purchase, (v) province or territory in which the substance was distributed? |
Answered |
Wednesday, November 19, 2025 |
|
Q-403
|
Friday, October 3, 2025 |
With regard to supervised consumption sites currently operating under Health Canada’s exemption authorization: how many supervised consumption sites, in total and broken down by province or territory, are located within 500 metres of a (i) school, (ii) daycare, (iii) playground, (iv) park, (v) seniors' home? |
Answered |
Wednesday, November 19, 2025 |
